You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

FML FORTE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Fml Forte patents expire, and what generic alternatives are available?

Fml Forte is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in FML FORTE is fluorometholone. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the fluorometholone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Fml Forte

A generic version of FML FORTE was approved as fluorometholone by AMNEAL on January 9th, 2024.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FML FORTE?
  • What are the global sales for FML FORTE?
  • What is Average Wholesale Price for FML FORTE?
Summary for FML FORTE
Drug patent expirations by year for FML FORTE
Drug Prices for FML FORTE

See drug prices for FML FORTE

Pharmacology for FML FORTE

US Patents and Regulatory Information for FML FORTE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie FML FORTE fluorometholone SUSPENSION/DROPS;OPHTHALMIC 019216-001 Apr 23, 1986 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.